“…Al-though it is somehow self-limiting, 25% of untreated patients with KD develop coronary artery abnormalities, which have accepted risks of inducing ischemic heart disease, coronary artery aneurysms, or sudden death (Anand and Anand, 1995;Brogan et al, 2002). Recent studies have suggested that apart from coronary artery abnormalities, patients with KD have a predominant pulmonary presentation, such as cough, pleural effusion, atelectasis, respiratory distress, and bronchial ar-tery stenosis (Ibrahim et al, 2017;Singh et al, 2018;Umezawa et al, 1989;Vaidya et al, 2017). Notably, pulmonary arterial hypertension (PAH), pulmonary artery dilation, pulmonary artery aneurysms, and right ventricle (RV) dysfunction have been observed in patients with KD (Briceno-Medina et al, 2016;Escalon et al, 2018;Nicholson et al, 2013;Ugi et al, 2010).…”